Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome

BACKGROUND: Guillain-Barré syndrome (GBS) is an autoimmune disease that results in demyelination and axonal damage. Five percent of patients die and 20% remain significantly disabled on recovery. Recovery is slow in most cases and eventual disability is difficult to predict, especially early in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Altmann, Patrick, De Simoni, Desiree, Kaider, Alexandra, Ludwig, Birgit, Rath, Jakob, Leutmezer, Fritz, Zimprich, Fritz, Hoeftberger, Romana, Lunn, Michael P., Heslegrave, Amanda, Berger, Thomas, Zetterberg, Henrik, Rommer, Paulus Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079539/
https://www.ncbi.nlm.nih.gov/pubmed/32183837
http://dx.doi.org/10.1186/s12974-020-01737-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079539/
https://www.ncbi.nlm.nih.gov/pubmed/32183837
http://dx.doi.org/10.1186/s12974-020-01737-0

Ejemplares similares